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The neuronal ceroid lipofuscinoses (NCLs) are a group of autosomal recessive neurodegenerative diseases char-
acterized by the accumulation of autofluorescent lipopigment in various tissues and by progressive cell death in
the brain and retina. The gene for variant late-infantile NCL (vLINCL), CLN6, was previously mapped to chro-
mosome 15q21-23 and is predicted to be orthologous to the genes underlying NCL in nclf mice and in South
Hampshire and Merino sheep. The gene underlying this disease has been identified with six different mutations
found in affected patients and with a 1-bp insertion in the orthologous Cln6 gene in the nclf mouse. CLN6 encodes
a novel 311–amino acid protein with seven predicted transmembrane domains, is conserved across vertebrates and
has no homologies with proteins of known function. One vLINCL mutation, affecting a conserved amino acid
residue within the predicted third hydrophilic loop of the protein, has been identified, suggesting that this domain
may play an important functional role.
The neuronal ceroid lipofuscinoses (NCLs) are a group
of autosomal recessive neurodegenerative diseases char-
acterized by the accumulation of autofluorescent lipo-
pigment in various tissues (Santavuori 1988). Clinical
features include visual failure, seizures, developmental
regression, and progressive mental and motor deterio-
ration. Naturally occurring NCLs are found in many
animal species, as well as humans, in whom at least seven
genetically distinct subtypes are known (Goebel et al.
1999). Six NCL genes have been identified to date; three
encode lysosomal enzymes (PPT1 [Vesa et al. 1995],
TPP1 [Sleat et al. 1997; Vines and Warburton 1999],
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and CTSD [Tyynela¨ et al. 2000]), and three encode pre-
dicted transmembrane proteins (CLN3 [International
Batten Disease Consortiums 1995], CLN5 [Savukoski et
al. 1998], and CLN8 [Ranta et al. 1999]). We mapped
CLN6, the gene for a variant late-infantile NCL (v-
LINCL [MIM 601780]) to chromosome 15q21-23, by
homozygosity mapping, in two consanguineous families
(Sharp et al. 1997). Further studies in additional families
narrowed the critical region to !1 cM (Sharp et al. 1999,
2001).
A BAC contig across the refined CLN6 critical region
(Sharp et al. 2001; R. B. Wheeler and J. D. Sharp, un-
published data) was constructed using a combination of
conventional physical-mapping methods and an in silico
approach. BLAST (Altschul et al. 1990), NIX, and the
Human Genome Browser were used to identify overlap-
ping BACs. Then, these BACs were analyzed using the
Tandem Repeat Finder program (Benson 1999) to iden-
tify new polymorphic markers across the contig. Two of
these markers (55782C and 90734.1) further refined the
critical region, to a distance that was encompassed by
seven BACs between AC055782 and AC090734 (see
supplementary information and the Human Genome
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Table 1
Genomic Structure of CLN6, Showing Splice-Site Junctions
EXON
SPLICE SITEa
3′ 5′
1 GCGCGCTCTCb TGCAGGCCAGgtgggcgcgc
2 tccttcccagGCATGGCTCT CATTGCCATGgtgagtgtga
3 tgctccgcagCTGGTATTCC CTTGCTCAAGgtactgtccc
4 tgaaccccagCTCATCGAGC GGAGACGCTGgtgaggccac
5 cctccctcagATCGACTCCT ACTGCATGTGgtgagtgatg
6 cctgtcacagGTACATCCCC TGTACTACTGgtgagtggac
7 gcctttccagGTACCTGGTC ACCGAGAGCATGA
a Exon sequence is shown in uppercase; intron sequence is shown
in lowercase.
b The 3′ splice site for exon 1 is the start of cDNA sequence
AK000568.
Table 2
CLN6 Mutations in Patients with vLINCL
Geographic Origin,
Genotype, and
Nucleotide Change
No. of
Families Mutation Amino Acid Change/Predicted Consequence
Location
(Exon)
Restriction-Site
Change
Greece:
Homozygous:
c.6delG 1 1-bp deletion Frameshift after E2 (extra 29 amino acids) 1 MnlI (loss)
Costa Rica:
Heterozygousa 1
Homozygous:
c.214GrT 6 Nonsense E72X 3 BfaI (gain)
c.368GrA 1 Missense G123D 4 BanI (loss)
Pakistan:
Heterozygousa,b 1
Homozygous:
c.316insCb 2 1-bp insertion Frameshift after P105 (extra 25 amino acids) 4 None
India:
Homozygous:
c.395_397delCT 1 2-bp deletion Frameshift after D131 (extra 17 amino acids) 4 HinfI (loss)
Portugal:
Heterozygousa 1
Homozygous:
c.460_462delATC 1 3-bp deletion I154del 4 None
NOTE.—For mutations in exons 1, 3, and 4, respectively, 26, 30, and 34 normal chromosomes were sequenced. Mutation no-
menclature is as recommended by den Dunnen and Antonarakis (2001).
a The second mutation has not been identified in these patients.
b This mutation is identical to that in the nclf mouse.
Browser). Transcripts were identified within the critical
region, by use of homology searches and gene-prediction
programs (NIX and the Human Genome Browser).
These included four known genes (DDXBP1, FEM1B,
ITGA11, andCLIPINC) and three novel genes with EST
and cDNA homologies (associated with Unigene clusters
Hs.239812, Hs.148759, and Hs.43654). On the basis
of functional information, none of the seven genes could
be prioritized as a disease candidate. Therefore, a sys-
tematic mutation-screening approach was adopted. For
each of the transcripts, we obtained full-length cDNA
sequence, identified exon-intron boundaries, and per-
formed expression analysis and mutation screening (R.
B. Wheeler and J. D. Sharp, unpublished data).
The cDNA AK000568 (Genome Database), coding
for the hypothetical protein FLJ20561, was associated
with Unigene cluster Hs.43654. This cDNAwasmapped
back to genomic sequence by use of BLAST to identify
exon-intron boundaries (table 1). Genomic primers were
designed for all seven exons (see supplementary infor-
mation), and sequence analysis of patient genomic DNA
revealed six different mutations in 15 families affected
with vLINCL (table 2; fig. 1 identifying this gene as
CLN6. AK000568 has a predicted open reading frame
of 936 nucleotides and comprises seven exons which
span a genomic region of ∼22 kb. One nonsense mu-
tation and three frameshift mutations are predicted to
result in the production of a truncated protein. A mis-
sense mutation and a mutation that results in the dele-
tion of a single amino acid were identified in exon 4.
Mouse ESTs homologous to CLN6 were identified by
BLAST analysis, and a partial cDNA sequence was ob-
tained which spans from exon 2 to the 3′ UTR. Addi-
tional 5′ sequence was identified from the mouse BLAT
alignments in the Human Genome Browser, and the
complete mouse cDNA was assembled. Five of the seven
exons were present in trace sequencing archives, and
genomic primers were designed for these (supplementary
information for exon 4 primers). A correspondingmouse
Unigene cluster was identified, Mm.30232, which maps
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Figure 1 Electropherograms showing genomic nucleotide sequence across mutation sites in two patients and the nclfmouse. a,Homozygous
1-bp insertion in exon 4 in a Pakistani patient (c.316insC). b, Normal control sequence. c, A 3-bp deletion in exon 4 in a Portuguese patient
(c.460_462delATC). d,Normal control sequence. e, A homozygous 1-bp insertion in exon 4 in the nclfmouse (c.301insC). f,Wild-type sequence.
The nclf mouse DNA was obtained from The Jackson Laboratory (stock no. 002628). Mutations were detected by direct sequencing of genomic
PCR products. PCR and sequencing primers are listed in the supplementary information. Each primer pair amplified the corresponding exon
and the flanking splice sites. PCR products were sequenced using ABI dye terminator chemistry (Applied Biosystems) and were visualized on
an ABI 373 sequencer (Applied Biosystems). Mutations were confirmed by sequencing in both directions.
to mouse chromosome 9 in the region of the nclf locus
(Bronson et al. 1998). A 1-bp insertion (c.307insC, caus-
ing a frameshift after P102) was identified in exon 4 of
Cln6 (fig. 1e) in the nclf mouse model (Bronson et al.
1998).
The CLN6 gene is predicted to encode a 311–amino
acid protein with seven transmembrane domains (fig. 2)
on the basis of TMHMM and TMAP transmembrane
prediction programs and hydrophobicity profiles (Kyte
and Doolittle 1982). Like other NCLmembrane proteins
(CLN3, CLN5, and CLN8), CLN6 has no homology
with known proteins or functional domains, although
the sequence is highly conserved across vertebrate species
(data not shown). There is 90% identity between the
human and mouse amino acid sequence (fig. 3). ESTs
corresponding to human CLN6 originated from a wide
variety of tissue libraries, and northern blot analysis con-
firmed ubiquitous expression of CLN6 (fig. 4). A tran-
script of 2.4 kb, consistent with the cDNA being nearly
full length, was present in all tissues. In addition, a tran-
script of 3.7 kbwas detected in all tissues, and transcripts
of 1.1 kb and 5.9 kb were present in skeletal muscle.
The majority of mutations result in a frameshift or
nonsense change, with the introduction of a premature
stop codon (table 2). However, one Portuguese patient
was homozygous for a 3-bp deletion, in exon 4
(c.460_462delATC), that is predicted to remove a single
amino acid (I154del) within the predicted third hydro-
philic loop of the protein (fig. 2a). This residue is within
a region of the protein that is highly conserved across
at least five species (human, mouse, cow, pig, and
chicken), suggesting that it is likely to have an important
role in the function of the protein. In addition, a Costa
Rican patient was homozygous for an exon 4 missense
540 Am. J. Hum. Genet. 70:537–542, 2002
Figure 2 A, Schematic representation of CLN6 structure, showing the seven predicted transmembrane domains based on TMHMM and
TMAP programs and hydrophobicity profiles. Single–amino-acid changes are indicated by asterisks (*). Exoplasmic and cytoplasmic surfaces
are indicated. B, Kyte and Doolittle hydrophobicity plot of the predicted CLN6 protein. All prediction programs were run using the Biology
Workbench.
mutation (c.368GrA) that changes glycine to aspartic
acid (G123D) within the predicted third transmembrane
domain. The introduction of a charged amino acid is
predicted to disrupt this domain.
A homologous region of exon 4 is mutated in the nclf
mouse and in three families of Pakistani origin, creating
an identical gene defect (see table 2). The genomic mu-
tation creates an insertion of a single cytosine within a
run of six cytosine residues, suggesting that it arises from
a common mutation mechanism: slipped mispairing dur-
ing DNA replication.
Unlike other forms of NCL, there is no evidence to
date for a commonCLN6mutation.We previously spec-
ulated on a common ancestry between Romany Gypsies
and natives of India and Portugal (Sharp et al. 1999).
However, the current data do not support this hypoth-
esis, since no exon 4 mutations have been detected in a
subset of Czech Romany Gypsy patients. A local founder
effect is present in Costa Rican subjects, with six of eight
patients homozygous for the same mutation in exon 3
(c.214GrT, E72X). However, one family was hetero-
zygous for this mutation, and a second family was ho-
mozygous for a different mutation in exon 4 (c.368GrA,
G123D). The higher-than-expected number of muta-
tions within this small inbred population provides evi-
dence that CLN6 may be a highly mutable gene. Two
distinct mutations have also been identified in three Pak-
istani families, providing further evidence to support this
observation (table 2).
CLN6 is the second gene to be identified with a cor-
responding mutation in the murine ortholog (Ranta et
al. 1999). In this case, it is also predicted to be orthol-
ogous to NCL-causing genes in two large animal models,
the South Hampshire sheep (Broom and Zhou 2001)
and the Merino sheep (Tammen et al. 2001), which will
be important in understanding the etiology of the dis-
ease. The availability of these animal models should al-
low exploration of the reasons for phenotypic differ-
ences between mammalian species carrying mutations at
one particular locus.
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Figure 3 A comparison between human and mouse CLN6 amino acid sequences. Dark shading indicates identical amino acids, and gray
shading indicates similar amino acids. Asterisks (*) denote the amino acid removed by the 3-bp deletion in a Portuguese patient (I154del) and
the missense mutation in the Costa Rican patient (G123D). Human and mouse protein sequences were aligned using ClustalW (Thompson et
al. 1997) and MacBoxshade 2.15E.
Figure 4 Human multiple-tissue northern blot (Clontech)
probed with a [32P]-labeled 808-bp fragment ofCLN6 cDNA spanning
from exon 3 to the 3′ UTR, according to the manufacturer’s instruc-
tions. In all tissues, 2.4-kb and 3.7-kb transcripts were detected, with
additional transcripts of 1.1 kb and 5.9 kb detected only in skeletal
muscle. A b-actin probe was used as a control for lane loading.
With the identification of the CLN6 gene, NCL-as-
sociated mutations are now defined in four novel
membrane proteins (CLN3, CLN5, CLN6, and CLN8)
that lead to a common cellular phenotype. These pro-
teins may all participate in an important basic biological
pathway that remains to be elucidated.
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